Cite
HARVARD Citation
Messadeg, L. et al. (2020). Early Transmural Response Assessed Using Magnetic Resonance Imaging Could Predict Sustained Clinical Remission and Prevent Bowel Damage in Patients with Crohn's Disease Treated with Anti-Tumour Necrosis Factor Therapy. Journal of Crohn's and colitis. pp. 1524-1534. [Online].